Sarepta Therapeutics



Ebitda Cambio Fecha
Acadia Pharmaceuticals USD 12.2M 22.01M 2024-12
Agios Pharmaceuticals USD -123670000 22.2M 2024-12
Alnylam Pharmaceuticals USD -90991000 28.07M 2024-12
Amgen USD 3.71B 265M 2024-12
Biogen USD 754.8M 7.2M 2024-12
BioMarin Pharmaceutical USD 194.85M 18.43M 2024-12
Daiichi Sankyo JPY 78.78B 31.82B 2024-12
Eli Lilly USD 6.17B 1.27B 2024-12
Gilead Sciences USD 3.21B 651M 2024-12
Incyte USD 320.2M 128.19M 2024-12
Insmed USD -241795000 46.45M 2024-12
Ionis Pharmaceuticals USD -105556000 37.61M 2024-12
Moderna USD -993000000 1.19B 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Pfizer USD 4.71B 3.04B 2024-12
PTC Therapeutics USD 1.07M 47.25M 2024-12
Regeneron Pharmaceuticals USD 1.06B 572.8M 2024-12
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.25B 2.22B 2024-09
Sarepta Therapeutics USD 182.21M 150.21M 2024-12
Tectonic Therapeutic USD -19213000 8.13M 2024-09
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Vertex Pharmaceuticals USD 1.16B 24.5M 2024-12



Sarepta Therapeutics - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.